Form 4: OS Therapies Inc: Shalom Auerbach Sells $284,300 Worth of Shares

Sentiment:

SEC Form 4


Shalom Auerbach, a director and 10% owner of OS Therapies Inc, sold 100,000 shares of common stock at an average price of $2.843 per share on February 14, 2025.

Summary

  • On February 14, 2025, Shalom Auerbach, a director and 10% owner of OS Therapies Inc (OSTX), sold 100,000 shares of common stock.
  • The shares were sold at a weighted average price of $2.843 per share, with individual transactions ranging from $2.67 to $3.036 per share.
  • Following the transaction, Auerbach directly owns 23,371 shares and indirectly owns 2,431,211 shares through Einodmil LLC.
  • Auerbach disclaims beneficial ownership of the shares held by Einodmil LLC, except to the extent of his pecuniary interest.
  • The sale was reported on February 18, 2025, in a Form 4 filing with the Securities and Exchange Commission.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard disclosure of stock sale by a director. The sale itself doesn't necessarily indicate a positive or negative outlook for the company.

Management Comments

  • Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

Industry Context

This is a routine disclosure of insider trading activity. It's common for directors and large shareholders to periodically adjust their holdings.

Stakeholder Impact

  • The stock sale could have a minor negative impact on shareholder sentiment in the short term.

Key Dates

DateDescription
02/14/2025Date of transaction (stock sale)
02/18/2025Date of Form 4 filing

Keywords

Form 4, OS Therapies Inc, OSTX, Shalom Auerbach, Einodmil LLC, Stock Sale, Beneficial Ownership, Director, 10% Owner

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.